These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16151471)

  • 41. The efficacy of darbepoetin alpha in hemodialysis patients resistant to human recombinant erythropoietin (rHuEpo).
    Hejaili F
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):590-5. PubMed ID: 19587498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
    Martelli O; Garassino M; Sacchetta S; Caristo R; Zivi A; Cerbone L; Mancuso A
    Anticancer Res; 2008; 28(3B):1767-71. PubMed ID: 18630457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients.
    Mahajan S; Boulton H; Gokal R
    J Nephrol; 2004; 17(5):687-92. PubMed ID: 15593036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates.
    Juul SE
    J Pediatr; 2003 Sep; 143(3):321-6. PubMed ID: 14517513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
    Blumer J; Berg S; Adamson PC; Loew T; Rossi G; Hastings C
    Pediatr Blood Cancer; 2007 Oct; 49(5):687-93. PubMed ID: 17120240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates.
    Carbajal R; Lenclen R; Jugie M; Paupe A; Barton BA; Anand KJ
    Pediatrics; 2005 Jun; 115(6):1494-500. PubMed ID: 15930209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.
    Kotto-Kome AC; Garcia MG; Calhoun DA; Christensen RD
    J Perinatol; 2004 Jan; 24(1):24-9. PubMed ID: 14726934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants.
    Langer J; Obladen M; Dame C
    J Pediatr; 2008 May; 152(5):728-30. PubMed ID: 18410782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.
    Tempera A; Stival E; Piastra M; De Luca D; Ottaviano C; Tramontozzi P; Marconi M; Cafforio C; Marcozzi P; Rossi N; Buffone E
    J Matern Fetal Neonatal Med; 2011 Aug; 24(8):1060-4. PubMed ID: 21250913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular effects of low-dose dexamethasone in very low birth weight neonates with refractory hypotension.
    Noori S; Siassi B; Durand M; Acherman R; Sardesai S; Ramanathan R
    Biol Neonate; 2006; 89(2):82-7. PubMed ID: 16158007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity.
    Beck D; Masserey E; Meyer M; Calame A
    Eur J Pediatr; 1991 Sep; 150(11):767-72. PubMed ID: 1959538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral iron supplementation in preterm infants treated with erythropoietin.
    Fujiu T; Maruyama K; Koizumi T
    Pediatr Int; 2004 Dec; 46(6):635-9. PubMed ID: 15660859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.
    Pathak A; Roth P; Piscitelli J; Johnson L
    Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F324-8. PubMed ID: 12819167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple dose pharmacokinetics of ciprofloxacin in preterm babies.
    Aggarwal P; Dutta S; Garg SK; Narang A
    Indian Pediatr; 2004 Oct; 41(10):1001-7. PubMed ID: 15523125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.
    Ohls RK; Kamath-Rayne BD; Christensen RD; Wiedmeier SE; Rosenberg A; Fuller J; Lacy CB; Roohi M; Lambert DK; Burnett JJ; Pruckler B; Peceny H; Cannon DC; Lowe JR
    Pediatrics; 2014 Jun; 133(6):1023-30. PubMed ID: 24819566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates.
    Chrysostomou C; Schulman SR; Herrera Castellanos M; Cofer BE; Mitra S; da Rocha MG; Wisemandle WA; Gramlich L
    J Pediatr; 2014 Feb; 164(2):276-82.e1-3. PubMed ID: 24238862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of erythropoietin following single-dose subcutaneous administration in preterm infants.
    Krishnan R; Shankaran S; Krishnan M; Kauffman RE; Kumar P; Lucena J
    Biol Neonate; 1996; 70(3):135-40. PubMed ID: 8894079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.
    Dame C; Langer J; Koller BM; Fauchère JC; Bucher HU
    Neonatology; 2012; 102(3):172-7. PubMed ID: 22776958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma erythropoietin concentrations during the early anemia of prematurity.
    Hågå P; Meberg A; Halvorsen S
    Acta Paediatr Scand; 1983 Nov; 72(6):827-31. PubMed ID: 6673483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.